Jean-Marc Bellemin

Jean-Marc Bellemin is an accomplished finance executive with extensive experience in leading financial operations across multiple companies in the pharmaceutical industry. Currently serving as Group CFO at Chiesi Group since July 2025, Jean-Marc has previously held the position of Chief Financial Officer at Iovance Biotherapeutics, Inc. from December 2020 to June 2025, and EVP & CFO at Gritstone Oncology from January 2018 to December 2020. Prior roles include SVP & CFO at Actelion and various financial leadership positions at Guerbet Pharmaceuticals, Elf Aquitaine, and Credit Lyonnais. Jean-Marc's educational background includes advanced degrees in finance and business management from prestigious institutions such as Harvard Business School and ESSEC Business School.